Fewer antibiotics are now consumed in Cyprus, yet the country still falls significantly short of the European target for the use of first-line medicines.
Despite a 25% decrease in overall consumption since 2019, new data from the European Centre for Disease Prevention and Control (ECDC) paint a picture with two sides: significant progress in quantity, but also serious challenges regarding the categories of antibiotics used.
Cyprus ranks sixth among the 27 member states of the European Union in terms of total antibiotic consumption, while it ranks among the four countries with the lowest use rate of antibiotics in the Access category, which are preferred for treating many common bacterial infections.
The data are included in the ECDC's annual epidemiological report for 2025, which was published on the occasion of today's European Antibiotic Awareness Day.
According to the report, antibiotic consumption in Cyprus in 2025 was 22.2 prescribed daily doses per 1,000 inhabitants, compared to 18.9 in the European Union.
In 2019, the corresponding figure in Cyprus was 29.6 daily doses, indicating a decrease of about 25% within six years.
This improvement is greater than that recorded at the European level, where total consumption decreased by about 5% over the same period.
However, Cyprus still consumes more antibiotics han the European average.
Only four out of ten first-choice picks
Even more telling is the picture that emerges from the distribution of antibiotics by category.
According to ECDC data, only 43.2% of total antibiotic consumption in Cyprus concerns the Access category, compared to 62.5% in the European Union.
The European target stipulates that by 2030, at least 65% of total antibiotic consumption should fall into this category.
Based on this data, Cyprus ranks fourth lowest among the 26 member states for which comparative data are available.
The Access category includes antibiotics recommended as treatment options for many common bacterial infections.
The World Health Organization's AWaRe classification divides antibiotics into three main groups: Access, Watch, and Reserve.
The Watch category includes antibiotics whose use requires increased caution, as they are associated with a higher risk of developing resistance, while the Reserve category concerns treatments mainly intended for severe infections caused by multidrug-resistant bacteria.
The use of antibiotics in the Watch and Reserve categories is not inherently wrong, as in many cases it is necessary. The problem arises when such treatments are chosen without corresponding medical need.
Tsioutis: We choose more easily promoted antibiotics
Mr. Konstantinos Tsioutis, scientific coordinator of the European Infection Control Board (EUCIC) and dean of the Medical School of the European University Cyprus, explained the practices observed in Cyprus.
As he explained, the issue is not about difficulty accessing newer therapeutic options, but about making it easier to choose advanced antibiotics even for simple infections.
«We choose more easily promoted antibiotics and second- and third-line antibiotics for simple infections," he notes.
According to Dr. Tsioutis, this practice has multiple consequences for both patients and the healthcare system.
First of all, it increases the cost of treatment, even in cases of simple community infections, financially burdening the healthcare system.
At the same time, the use of more advanced antibiotics without necessarily increases the likelihood of side effects, as well as the risk of interactions with other medications the patient may be taking.
The problem, therefore, is not limited to how many antibiotics are consumed but also extends to which drugs are chosen to treat each infection.
Antibiotics even for viral infections
In his initial statement on the occasion of today, Mr. Tsioutis points out that Cyprus is experiencing excessive use of broad-spectrum antibiotics both in the community and in hospitals.
At the same time, he notes that antibiotics are often prescribed for viral infections, such as the common cold and the flu, even though these drugs have no effectiveness against viruses.
Antibiotics work against bacteria, not viruses. Therefore, administering them to treat a virus, without a bacterial infection requiring treatment, does not benefit the patient.
Rational use requires that the appropriate antibiotic is selected based on the specific infection and administered at the correct dose for the recommended duration.
Special attention to children
At the heart of this year's ECDC campaign are children, with particular emphasis on informing parents about the proper use of antibiotics.
Most common upper respiratory infections in childhood are caused by viruses and do not require antibiotic treatment.
Mr. Tsioutis points out that early and unnecessary exposure of children to antibiotics can disrupt their microbiome, increasing the risk of future health problems.
For this reason, antibiotics should be given to children only when there is a real medical need and according to the treating physician's instructions.
Close to one target, far from the other
Of particular interest is the fact that Cyprus is now close to the national quantitative target for 2030, which has been set at 22 set daily doses per 1,000 inhabitants.
With the index set at 22.2 instalments in 2025, the gap from this target is now short.
In contrast, the country still falls significantly short of the European target for the consumption of Access category antibiotics, with its rate falling to 43.2%, compared to the target 65%.
This difference highlights that the reduction in overall consumption, although significant, is not enough on its own.
As Mr. Tsioutis points out, the State is strengthening national monitoring of the relevant indicators and promoting the operation of Antibiotic Logistics Teams in hospitals.
However, ensuring the effectiveness of antibiotics and patient safety requires continuous and coordinated efforts.
"The goal for Cyprus is no longer only to limit the amount of antibiotics it consumes, but also to improve the way they are selected and used."
